Introduction
Genomic imprinting is an epigenetic mechanism by which a subset of mammalian genes are regulated. Imprinted genes are organized into clusters throughout the genome and are commonly regulated by an imprinting center region (ICR) (Edwards and Ferguson-Smith, 2007; Smith, et al., 2003) . ICRs undergo parent-specific methylation on the cytosine residues of CpG dinucleotides during gametogenesis. This differential methylation regulates the allelespecific expression of several genes in the cluster (Morgan, et al., 2005; Reik, et al., 2003) . A loss of imprinting (LOI) of such genes, through a gain (GOM) or a loss of DNA methylation (LOM), has been implicated in many human diseases and cancer (Robertson, 2005) .
Human chromosome 11p15 encompasses two imprinted domains playing an important role in controlling fetal and postnatal growth. Each domain is differentially methylated and regulated by its own ICR [ICR1 which is paternally methylated, located in the telomeric region and regulates the H19/IGF2 domain (OMIM: 103280/147470, respectively); ICR2 which is maternally methylated, located in the centromeric region and regulates the KCNQ1/CDKN1C domain (OMIM: 607542/600856, respectively)]. LOI in these two domains has been implicated in two clinical growth disorders with opposite phenotypes. LOM at ICR1 is found in more than 50% of patients with Russell-Silver Syndrome (RSS) (Gicquel, et al., 2005; Netchine, et al., 2007) , whereas a GOM at ICR1 is found in 10% of patients with Beckwith
Wiedemann syndrome (BWS) (Gaston, et al., 2001; Reik, et al., 1995) . Abnormal DNA methylation (LOM) at ICR2 is only involved in BWS (60% of BWS cases) ( Figure 1 ) (Gaston, et al., 2001; Reik, et al., 1995) .
BWS (OMIM 130650 ) is characterized by pre-and postnatal overgrowth, macroglossia, abnormal wall defects, hemihyperplasia and an increased risk of childhood tumors (Cooper, et , 2005; Gaston, et al., 2001; Schneid, et al., 1993) . By contrast, RSS (OMIM 180860) is a syndrome firstly described by Silver et al. (Silver, et al., 1953) and Russell (Russell, 1954) . It is characterized by pre-and postnatal growth retardation, a prominent forehead, relative macrocephaly, body asymmetry and feeding difficulties and/or a body mass index < -2 SDS (Netchine, et al., 2007) .
Our center has, for many years, been the national reference center for the molecular diagnosis and the clinical follow up of both RSS and BWS. The method we have been using for the diagnosis of RSS and BWS at our center is based on Southern blotting with methylationsensitive enzymes, for the detection of methylation abnormalities of ICR1 and ICR2 11p15 region (Gaston, et al., 2001; Netchine, et al., 2007; Schneid, et al., 1993) . This technique is effective, but is time-consuming, requires large amounts of DNA and radioactivity (α 32 P-CTP) and involves many different steps that might introduce technical problems.
Furthermore, the procedures involved take a long time and the results of the test are obtained in about 15 days.
Several other methods of DNA methylation analysis have been assessed as possible replacements for Southern blotting (Fraga and Esteller, 2002) . Sodium bisulfite DNA treatment followed by sequencing is one method providing detailed information about all the CpGs in a region of interest. This method generally requires cloning and transfection of bacteria that might entailing risks of contamination and false positives, and is also very timeconsuming. Another alternative to this technique is pyrosequencing, which is also based on sodium bisulfite treatment of the DNA, but without the need for cloning. This technique has the advantage of being quantitative and providing information about the methylation status of each CpG in the sequence studied. Methyl-sensitive PCR has been used by several groups to study the differential methylation status of imprinted regions after sodium bisulfite DNA DNA methylation within the genome, particularly in the context of cancer (Cottrell, et al., 2004; Eads, et al., 2000; Khulan, et al., 2006; Thomassin, et al., 2004; Trinh, et al., 2001; and for the diagnosis of Angelman Syndrome, RSS and BWS (Alders, et al., 2009; Bruce, et al., 2008; Coffee, et al., 2006; Nazlican, et al., 2004; Priolo, et al., 2008; Wojdacz, et al., 2008; Zeschnigk, et al., 2008) . One of these techniques is methylationspecific multiplex ligation-dependent probe amplification (MS-MLPA) Priolo, et al., 2008; Scott, et al., 2008 (Netchine, et al., 2007) and were included in this study. Methylation analysis was assessed blind to the molecular diagnosis previously obtained by Southern blotting.
We then studied a prospective cohort (n=82) consisting of all the DNA samples from patients referred to our laboratory for molecular diagnosis of RSS or BWS, over a period of nine months [May 2007 -January 2008 . Methylation index (MI) was determined independently of the clinical data available for each case. Subsequently, 69 among them, for whom DNA was still available, were analyzed also by MS-MLPA.
Southern blotting analysis
We used methylation-sensitive Southern blotting to analyze the methylation status of ICR2, and of ICR1 in the 11p15 region, as previously described (Gaston, et al., 2001; 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Sodium bisulfite DNA treatment
Sodium bisulfite DNA treatment converts all the unmethylated cytosine residues in CpG dinucleotides to thymidine residues. The methylated cytosine residues are unaffected. This process thus generates C/T polymorphisms, which can be used to distinguish between the methylated and the unmethylated allele. Genomic DNA (1 µg) was treated with sodium bisulfite, with the EZ DNA Methylation kit (Zymo Research, Orange, CA), according to the manufacturer's instructions. It was then eluted with 50 µl RNase-free H 2 O.
TaqMan Allele-Specific Methylated Multiplex Real-Time Quantitative PCR (ASMM RTQ-

PCR)
Design of probes and primers
Probes and primers were designed based on sequences with the following accession numbers from GenBank: NW 001838018.2 for ICR2 and AF125183 for ICR1 CTCF binding site 2 (CBS2) (Figure2). These two sequences encompass the NotI and SmaI sites, respectively, analyzed in the Southern blotting method. Probes and primers were designed with Primer Express version 3.0 (Applied Biosystems, France). We have designed two TaqMan minor groove-binder (MGB) probes (TaqMan-MGB probes) specifically recognizing the methylated and unmethylated alleles. The primers were designed to recognize both alleles, without discrimination. We avoided the inclusion of CpG dinucleotides in the primer sequences as far as possible to ensure that the methylated and unmethylated alleles were amplified equally efficiently. Our TaqMan-MGB probes contained at least two C/T nucleotides, to ensure high stringency, so that the hybridization of probes to each allele was very specific. The probes 
Principle underlying ASMM RTQ-PCR
The ASMM RTQ-PCR is based on the allele discrimination technology used for SNP genotyping and absolute TaqMan probe quantification from standard curves, a method commonly used to quantify gene expression. Following the treatment of the DNA with sodium bisulfite, a C/T polymorphism is generated in the native CpG, depending on the methylation status of the cytosine residue. Discrimination between the two alleles is based on the use of two probes specifically recognizing the methylated allele (containing the "C" residue) or the unmethylated allele (containing the "T" residue). One of the conditions for TaqMan probe-based amplification is that the melting temperature (Tm) of the probe must be at least 10°C higher than that of the primers, ensuring that the probes hybridize to the target sequence before the primers. However, sodium bisulfite treatment decreases DNA sequence stringency, limiting thereby the design of appropriate probes and primers respecting this requirement. The addition of the MGB molecule at the 3' end of the probe increases the Tm of the probe, permitting thereby to shorten its sequence. By designing TaqMan-MGB probes, we have thus overcome the limitations imposed by sodium bisulfite DNA treatment. At steady state (before the initiation of amplification), the reporter dye is close to the quencher dye, resulting in the extinction of reporter dye fluorescence, principally by Förster resonance energy transfer (FRET). By contrast, during primer extension (elongation step of the PCR), the DNA polymerase, via its 5'-exonuclease activity, cleaves only probes hybridized to the target sequence. Cleavage releases the reporter dye into the medium, where it becomes fluorescent following laser excitation (Figure 3 ). This phenomenon occurs in each cycle of the 
DNA sequencing
We checked primer specificity, by sequencing the two fragments corresponding to ICR1 CBS2 and ICR2, using the same primers as used for ASMM RTQ-PCR, the ABI PRISM Big Dye Terminator v1.1 cycle sequencing kit and an ABI 3100 Genetic Analyzer (Applied Biosystems). Sequences were analyzed with Sequence Navigator and Edit View software from ABI Prism.
MS-MPLA analysis method
Five hundred ng of DNA from 50 control subjects and 69 patients from the prospective cohort, for whom DNA was still available, were subjected to methylation status analysis using the methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) SALSA ME030B kit (MRC Holland, Amsterdam/NL) according to the manufacturer's protocol. The MIs were calculated using the recommended Coffalyser version 8.0
Directmethylation status analysis method (MRC Holland, Amsterdam/NL). The MI at both ICR1 and ICR2 were determined for each subject by the average of all MIs of target CpGs.
Statistical analysis
MIs are reported as means ± SD. Agreement between the MI values obtained by Southern blotting and ASMMRTQ-PCR was assessed by calculating intra-class correlation coefficients (ICC) (Shrout and Fleiss, 1979) and determining the 95% confidence interval by bootstrapping. Based on the MI values obtained for ICR1 and/or ICR2, a diagnosis of RSS or BWS was established or excluded. The acceptance or exclusion of the diagnosis was treated as a qualitative value in our statistical analysis. Agreement between the two tests, in terms of (Cohen, 1960) . Intraclass correlation coefficients and kappa coefficients indicate the degree of similarity between the results obtained with the two methods. An ICC or kappa coefficient greater than or equal to 0.9 was considered excellent.
Bland and Altman plots were generated to check that within-subject repeatability was not related to the size of the MI (Bland and Altman, 1986) . Difference (MI ASMMRTQ-PCR -MI Southern blot ) against the average of MI ((MI ASMMRTQ-PCR + MI Southern blot )/2). "Limits of agreement" is defined by the mean difference (Cohen, 1960) and the standard deviation of the difference as dm ± SD. Descriptive analysis was carried out and a weighted kappa coefficient was calculated with the SAS V9 System (SAS Institute, Cary, NC, USA). The ICC and its 95% CI were calculated and Bland and Altman plots were generated with R software version 2.0 (R Foundation for Statistical Computing, Vienna, Austria; www.R-project.org).
Results
Development of the ASMM RTQ-PCR technique
Before analyzing the methylation status of DNA from patients and controls, we checked the specificity of primers and probes and evaluated the sensitivity of this technique.
Primer specificity
The specificity of the primers was evaluated by direct sequencing of the amplification product of CBS2 ICR1 and ICR2 of a control DNA sample with the same primers used in the ASMM RTQ-PCR experiment. The expected C/T dinucleotide polymorphisms were identified at the CpG dinucleotides for both CBS2 ICR1 and ICR2 sequences (Supp. Figure S1 ). These results demonstrate the high specificity of the primers and the efficacy of sodium bisulfite DNA treatment. The standard curves for the methylated and unmethylated probes were used to calculate the efficiency of the assay. The amplification efficiencies of CBS2 ICR1 and ICR2 were 98% and 90%, respectively, and the correlation coefficients (R²) exceeded 99% for both regions. These results demonstrate the high amplification yield of our assay (Supp. Figure S2 ).
Efficiency, specificity and sensitivity of the ASMM RTQ-PCR
We checked the specificity of probe hybridization to each allele and investigated whether our technique could detect subtle differences in methylation, using EpiTech control DNAs. These control DNAs are of two types: totally unmethylated or totally methylated. The probes for quantifying the CBS2 ICR1 and ICR2 regions were highly specific, with no cross hybridization between the two alleles. The methylated EpiTect DNA is obtained enzymatically, and displays about 95% methylation, according to the manufacturer. Our results for the methylated probes for ICR2 were consistent with this value (94%). The MIs calculated for the mixtures of EpiTech DNAs in various proportions were consistent with theoretical expectations for the two regions (Supp. Figure S3 ). Thus, these results demonstrate the high specificity of our probes and the high sensitivity of our assay.
Clinical validation
We have firstly validated ASMM RTQ-PCR by comparing it to our gold-standard method, Southern blotting. Since MS-MPLA is becoming increasingly used as an analytical technique for DNA methylation assessment particularly for RSS and BWS diagnosis, we secondly assessed a comparison of the three methods in the prospective analysis group of patients.
Control subjects
We first analyzed the methylation of the CBS2 ICR1 and ICR2 regions of DNA from 64 controls, by both Southern blotting and ASMM RTQ-PCR. The MIs calculated for the control subjects were normally distributed, which allowed us to calculate a mean MI and standard deviation (SD). The MIs calculated for CBS2 ICR1 and ICR2 by the two methods were concordant ( Figure 4 A and B) . The intra-and inter-assay coefficients were calculated for ASMM RTQ-PCR, and both were found to be 6% (data not shown). We considered a MI to be normal if it was within two standard deviations of the mean MI value for control subjects, and abnormal if it was outside this range (Figure 4 B) .
Patients
In the retrospective study, the patients were analyzed by ASMM RTQ-PCR, blind to the molecular diagnosis previously obtained by Southern blotting. In the prospective study, the patients were analyzed by both methods, blind to the clinical data. An example of the amplification curves of control subjects and patients with LOM at CBS2 ICR1 or ICR2 is shown in supplementary data (Supp. Figure S2 ).
Clinical application
Retrospective RSS population
In the 50 identified cases of RSS, the mean MI of CBS2 ICR1 assessed by ASMM RTQ-PCR was 28±20 and that assessed by Southern blotting was 32±17. The ICC was 0.89 [0.84-0.92] (Supp. Figure S4A ). For the qualitative results, 62% of samples showed LOM by both techniques, indicating maximal levels of agreement (kappa=1; Supp. Table S1 ).
Retrospective BWS population
The mean MI of CBS2 ICR1 was 60±13 by ASMMRTQ-PCR and 58±12 by Southern Three cases identified as LOM by Southern blotting were identified as normal by ASMM RTQ-PCR (Supp . Table S2 ). These three patients all had a borderline MI (46%) on Southern Figure S4C ). No divergence between the two techniques was observed for qualitative results. Both identified 64% of samples as LOM and 36% as displaying normal DNA methylation (kappa= 1; Supp. Table S3 ).
Prospective population
The MI values for CBS2 ICR1 and ICR2 are presented in Table 2 .
CBS2 ICR1 11p15
The mean MI value for CBS2 ICR1 11p15 assessed by ASMM RTQ-PCR was 50±10, and that assessed by Southern blotting was 54±8. The quantitative agreement coefficient was 0.78
[0.59 -0.86]. A Bland and Altman plot was generated to investigate the variation between individuals ( Figure 5A ). We identified four extreme points resulting in a positive slope for the overall plot, indicative of a proportional error. The MI value obtained by Southern blotting was systematically higher than the value obtained by ASMM RTQ-PCR.
Three disagreements concerning the qualitative result were identified (Table 3) 
ICR2 11p15
The mean MI value for ICR2 11p15 was 42±14 when assessed by ASMM RTQ-PCR and 42±13 when assessed by Southern blotting. Quantitative agreement was excellent (ICC=0.96
[0.92 -0.98]). Bland and Altman plots showed that most of the differences lay within the confidence interval of the difference, with the exception of three points ( Figure 5B ). 
MS-MLPA analysis results
We analyzed the methylation status of ICR1 and ICR2 11p15 region for 50 control subjects and 69 patients from the prospective population for whom DNA was still available. The mean and SD calculated from the control population were 55±3 % (range 49-61%) and 60±4 % (range 52-68%) for ICR1 and ICR2, respectively. This range is larger than that obtained by ASMM RTQ-PCR and Southern blotting (Supp. Figure S5 ). According to these ranges, the diagnosis established with MS-MPLA is concordant in 80% of the cases (55/69) with that established by ASMM RTQ-PCR and Southern blotting; whereas in 20% of the cases (14/69) there is a discordance between the three methods (Supp. We have developed a technique for analysis of the methylation of CBS2 ICR1 and ICR2 in the 11p15 region, for the molecular diagnosis of RSS and BWS. We first validated the primers and probes used, and then studied a large cohort of patients (given that both these conditions are rare) and control subjects, by both Southern blotting and ASMM RTQ-PCR.
Since the MS-MPLA is also used for RSS and BWS diagnosis, we secondly assessed with this method a sub-group of the patients analyzed in the prospective analysis to allow a comparison between the three methods.
Human ICR1 in the 11p15 region contains seven CTCF binding sites (CBS) within two repetitive sequences and displays a high degree of sequence identity (Frevel, et al., 1999) .
This makes it difficult to design primers and probes specific for the CBS to be analyzed (CBS2). For consistency with the analysis of 11p15 region methylation by Southern blotting, we designed probes for ASMM RTQ-PCR containing the restriction sites (Netchine, et al., 2007; Rossignol, et al., 2006) used over many years in the diagnosis of RSS and BWS by Southern blotting (Figure 2 ). Direct sequencing of the amplification products and the EpiTech control DNAs demonstrate that our primers and probes were highly specific to the regions of interest, CBS2 ICR1 and ICR2, with no cross hybridization observed in the multiplex amplification assay. Using the EpiTech control DNAs, we also demonstrated ASMM RTQ-PCR to be a highly robust and sensitive assay. Methylation abnormalities generally occur as mosaics (Gaston, et al., 2001; Gicquel, et al., 2005; Nazlican, et al., 2004; Netchine, et al., 2007; Schneid, et al., 1992; Schneid, et al., 1993) , making it very difficult to identify patients with low degree of LOI. Our results indicate that the risk of false positives is lower with ASMM RTQ-PCR than with Southern blotting. Moreover, the high sensitivity of this assay increases the likelihood of identifying patients with low degree of LOI. We validated our technique by comparing the MIs of control subjects calculated by Southern blotting (goldstandard method) and by ASMM RTQ-PCR. The MI values were normally distributed, which However, when we consider the quantitative results obtained by calculating the MI for the two methods, the ICC obtained was smaller for CBS2 ICR1. The small discrepancy between the two methods may be accounted for by differences in the characteristics of the two methods.
Southern blotting is a quantitative method requiring the hybridization of a radiolabeled probe to digested DNA transferred onto a membrane. This hybridization may generate a background signal, decreasing the accuracy of the signal intensities obtained when the bands are scanned and thus affecting MI calculation. By contrast, the ASMM RTQ-PCR is based on the quantification of fluorescence from the reporter dye after primer elongation. This fluorescence is normalized with respect to a reference dye (ROX) in the reagent mixture, the fluorescence CpGs between the primers, remain laborious and are not free from contamination risks (Fraga and Esteller, 2002) . Another alternative to this method is pyrosequencing, which does not require subcloning, being based instead on the direct sequencing of amplification products.
This technique provides quantitative information about methylation at each CpG in the sequence of interest and is therefore potentially promising. However, it remains expensive and
is not yet available for diagnostic purposes in many institutions. Other methods based on sodium bisulfite DNA treatment and quantitative amplification require efficiency optimization (Cottrell, et al., 2004; Thomassin, et al., 2004) and some are limited to analysis of the methylation status of only one allele at a time and, therefore, cannot provide accurate information (Eads, et al., 2000; Trinh, et al., 2001 QiaGen has been developed some TaqMan assays to study the methylation status of promoters of certain genes involved in cancer. The principle of their assays is substantially the same as our since they use two allele-specific probes to quantify the methylated and the unmethylated alleles. Our assay assesses the methylation study of imprinted loci for which the methylation status is balance between the parental alleles. By contrast, QiaGen's assays are developed to study the methylation changes of non imprinted promoters. The methylation of such regions could be different between CpGs and could hinder the hybridization of the probes which could introduce an error of MI calculation. The MI is calculated using the ratio of the cycle threshold (C T ) of the methylated and unmethylated allele in the same sample. To be more accurate, this calculation requires the use of a control probe in the same assay so that to normalize the DNA amount. We used the standard curve to determine the MI. This method of calculation (standard curve) does not need the use of a control probe for normalization, since the quantity of each allele is calculated by the standard curves. For the diagnosis of RSS and BWS, Wojdacz et al and Alders et al (Alders, et al., 2009; Wojdacz, et al., 2008) have recently developed a methylation-sensitive high-resolution melting (MS-HRM) method for the methylation analysis of the H19 promoter. Although this method is reliable, it is however difficult to identify low degree of LOI present in pUPD11, 11p duplications and 11p15 epimutation as these abnormalities are frequently in mosaics.
Some other methods based on the use of methylation-sensitive restriction enzymes have also been developed for methylation analyses. These methods focus on a single CpG, and may therefore fail to detect certain individuals with low degree of LOI, necessitating additional testing on proximal regions (Bruce, et al., 2008) . The methylation-specific multiplex ligationdependent probe amplification assay (MS-MLPA) was also developed for analysis of methylation in the 11p15 region for the diagnosis of RSS and BWS Priolo, et al., 2008; Scott, et al., 2008) . It uses a set of probes hybridizing at ICR1 and ICR2, (Priolo, et al., 2008; Scott, et al., 2008) . Since these reports, the SALSA ME030B probe mix has been changed. It should be noted that all the methyl-specific probes hybridizing to H19DMR are located in the promoter region of H19 gene except one (08745-L08765) that is located between CBS6 and CBS7 ( Figure 2 ). It is recognized that ICR1 is the imprinting centre that regulates the telomeric region of the 11p15 region. Furthermore, uneven methylation has been previously reported at the promoter region of H19 (Vu, et al., 2000) and dissociation between the methylation status and H19 promoter has been reported in RSS patients (Horike, et al., 2009 ). Improvements are therefore required in the SALSA ME030B probe set, together with a careful analysis and validation of the results.
ASMM RTQ-PCR is easy to perform, reproducible, robust and highly sensitive. Results can be obtained in one and half days, and the analysis is very easy to monitor. In addition, the use of real-time PCR reduces the handling errors associated with manual manipulation, by decreasing the number of laboratory steps performed in the assay. Moreover, ASMM RTQ- Robust and reliable techniques are required for molecular diagnosis of these abnormal patterns of methylation occurring as mosaics. This technique is currently transferred for the diagnosis of RSS and BWS in our laboratory and substituted to Southern blotting and allows accurate diagnosis with a small DNA quantity. This is the first step to allow the development of an antenatal diagnosis for both RSS and BWS. In our experience, there is an increasing demand for BWS and RSS antenatal diagnosis to improve the obstetrical follow-up of these pregnancies and orient the medical counseling in case of severe IUGR or overgrowth syndrome during the pregnancy. Because of severe intra-uterine growth retardation, RSS fetuses are often delivered by the obstetricians before term. However, they then frequently have neonatal complication and this could be avoided if the diagnosis was known as they usually have a good tolerance to in utero gestation until term. Since the methylation anomalies of the 11p15 region occur in a mosaic manner, this diagnosis is very delicate in cases of low degree of LOI and mosaicism and requires a very reliable method that needs very small amount of DNA, extracted directly from the amniocytes pellet without a step of culture.
ASMM RTQ-PCR technique responds to these requirements and will make possible to develop such a diagnosis. Furthermore, ASMM RTQ-PCR could be adapted for studies of methylation status at other imprinted loci involved in human syndromes and has been used for the evaluation of seven other imprinted loci as part of a multilocus study on our cohort of RSS and BWS patients with LOI at 11p15 (Azzi, et al., 2009 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The CpG position before sodium bisulfite DNA treatment are underlined. Tables   Table S1: Qualitative results for CBS2 ICR1 for the RSS population in the retrospective study A= abnormal DNA methylation (LOM), N = normal DNA methylation Table S2 : Qualitative results for CBS2 ICR1 for the BWS population in the retrospective study 
Southern blotting conclusion
